News
Oval will be attending BIO-Europe in Copenhagen from the 5th-7th November 2018. BIO-Europe is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors. We welcome you to contact us if you wish to arrange a meeting
More...Oval and SMC Ltd. will be attending PDA in Florida from the 8th-10th October 18. We will be exhibiting at booth 416 and would welcome the opportunity to discuss and demonstrate our delivery platforms and integrated approach to autoinjector design.
More...Injection Devices: As Self-Injection Grows, Drug Delivery Gets Smarter
More...Oval Medical Technologies and SMC Ltd. will be exhibiting at Pharmapack Europe today in Paris. Please pay us a visit at stand F34.
More...Congratulations SMC Ltd for the 30 year business anniversary which was celebrated on 1 February. SMC’s expertise combined with Oval’s autoinjector leadership will deliver partners’ medicines with sustainable competitive advantage. See the new SMC website at: www.smcltd.com
More...In celebration of the holiday season, Oval will be closed from Dec. 25, 2017 – Jan. 1, 2018. We wish our colleagues and friends around the world a happy and safe holiday season and a wonderful New Year.
More...Oval Medical will be attending BIO-Europe in Berlin from the 6th-8th November 2017. BIO-Europe is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors. We welcome you to contact us if you wish to arrange a meeting.
More...Oval Medical Technologies and SMC Ltd. will be attending PDA Europe in Vienna from the 6th-8th November 2017. We will be exhibiting at booth 100 and 101 and would welcome the opportunity to discuss and demonstrate our delivery platforms and integrated approach to autoinjector design. We will also be demonstrating our injection characterisation system which…
More...Oval’s team encompasses a wide range of skills and expertise allowing us to develop and deliver to market innovative autoinjection platforms to suit every patient’s need.
More...Oval Medical CEO Barbara Lead CEO will be supporting the Aurora Project – an initiative focused on patient centricity and patients as partners. The project will be meeting at eyeforpharma in Barcelona from the 14-16 March. Find out more about the project at the following link: https://lnkd.in/gVTtx6
More...